EPIX Pharmaceuticals Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2008-01-08

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

EPIX Pharmaceuticals is a clinical-stage biopharmaceutical company focused on small molecule drug discovery and development with pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. The company's lead product, Vasovist is marketed in 32 European nation and waiting for the approval in US.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    EPIX Pharmaceuticals' proprietary development program integrates computational methods with the medical chemistry which addresses the inefficiencies associated with the traditional methods of drug discovery.The company has four therapeutic product candidates in clinical trials for depression, Alzheimer's disease, cardiovascular disease and obesity.

    EPIX Pharmaceuticals derives its revenues from royalties, license and collaboration fees. The company's total revenues decreased from $12 million in 2004 to $4 million in 2006.

    EPIX Pharmaceuticals' total revenues are forecasted to expand by a CAGR of 66% over the period 2006-2010. The growth is attributed to the royalties, license, collaboration, and others, anticipating the company's business development deals and clinical developments of its early stage drug candidates.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: EPIX Pharmaceuticals epix vasovist pharmaceuticals jones simon pharmaceutical supplier share inc revenues

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.